These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 24641311)

  • 1. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
    Mishra D; Jain N; Rajoriya V; Jain AK
    J Pharm Pharmacol; 2014 Aug; 66(8):1082-93. PubMed ID: 24641311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
    Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
    Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and evaluation of bioactive drug-loaded polymeric nanoparticles for drug delivery.
    Rani R; Dilbaghi N; Dhingra D; Kumar S
    Int J Biol Macromol; 2015; 78():173-9. PubMed ID: 25881957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel serum-stable liver targeted cytotoxic system using valerate-conjugated chitosan nanoparticles surface decorated with glycyrrhizin.
    El-Marakby EM; Hathout RM; Taha I; Mansour S; Mortada ND
    Int J Pharm; 2017 Jun; 525(1):123-138. PubMed ID: 28392279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
    Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
    Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan nanoparticles as adenosine carriers.
    Kazemzadeh-Narbat M; Reid M; Brooks MS; Ghanem A
    J Microencapsul; 2015; 32(5):460-6. PubMed ID: 26052724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on drug-polymer interaction, in vitro release and cytotoxicity from chitosan particles excipient.
    Gomathi T; Govindarajan C; Rose H R MH; Sudha PN; Imran PK; Venkatesan J; Kim SK
    Int J Pharm; 2014 Jul; 468(1-2):214-22. PubMed ID: 24742716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
    Wang F; Yang Y; Ju X; Udenigwe CC; He R
    J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
    Abouelmagd SA; Ku YJ; Yeo Y
    J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy.
    Chen X; Yu S; Wang P; Zhao X; Sang G
    Recent Pat Anticancer Drug Discov; 2024; 19(2):154-164. PubMed ID: 38214355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
    Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
    Liu P; Zhao X
    Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.